BrainQ

BrainQ is an Israeli neurotechnology company developing AI-powered, non-invasive electromagnetic therapy for stroke recovery. Its BrainQ BCI device delivers frequency-tuned electromagnetic stimulation to enhance brain recovery after ischemic stroke. The EMAGINE pivotal trial is enrolling 150 patients across 20 US clinical sites.

BrainQ has 1 robot model on the DEPLOY registry: BrainQ Non-Invasive BCI (BrainQ builds both physical robots and the AI that runs them).

No. BrainQ is privately held and not publicly traded, per the DEPLOY registry.

On the DEPLOY registry, peer companies to BrainQ building in the same form factors include Google, Samsung Electronics, Butterfly Network, Abbott.

Yotam Drechsler is the founder of BrainQ, per the DEPLOY registry.

BrainQ is a private company; its shares are not available on public markets, so retail investors cannot buy the stock today. It has raised $40M in disclosed funding.

BrainQ is headquartered in Israel.

BrainQ has raised approximately $40M in disclosed funding on record in the DEPLOY registry.

BrainQ is privately held and venture-backed ($40M raised); ownership sits with its founders and private investors.

BrainQ operates 3 verified deployments, including at White Plains, New York, USA, Miami, Florida, USA, Washington, DC, USA.

DEPLOY has 3 verified BrainQ deployments on record at sites including White Plains, New York, USA, Miami, Florida, USA, Washington, DC, USA. That is a count of distinct field deployments each backed by sourced evidence, not a manufacturer's claimed unit total; it updates as new sites are verified.

On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, BrainQ ranks in roughly the top 19% of companies tracked by the registry.

BrainQ has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.